论文部分内容阅读
目的:探讨米非司酮治疗子宫肌瘤的临床效果。方法:57例子宫肌瘤患者口服米非司酮25 m g,每日1次睡前服,连服3个月。于治疗前后均用B超监测子宫及肌瘤体积、血尿常规、血糖、肝功能等指标。结果:患者均出现闭经,症状消失,肌瘤消失者21例,肌瘤明显缩小者25例,血红蛋白恢复正常,血糖较治疗前降低。结论:米非司酮治疗子宫肌瘤有一定效果,不良反应小,是一种可行的保守治疗方法。
Objective: To investigate the clinical efficacy of mifepristone in the treatment of uterine fibroids. Methods: 57 cases of uterine fibroids oral mifepristone 25 m g, 1 times a day before bedtime service, and even for 3 months. Before and after treatment with B-monitoring of uterine and fibroid volume, hematuria, blood glucose, liver function and other indicators. Results: All patients had amenorrhea, symptoms disappeared, fibroids disappeared in 21 cases, fibroids significantly reduced in 25 cases, hemoglobin returned to normal, blood glucose decreased compared with before treatment. Conclusion: Mifepristone treatment of uterine fibroids have a certain effect, small adverse reactions, is a viable conservative treatment.